T

Mingjing Zhu1, Pian Li1,2, Huisi Zhang1

  • 1Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.

概括

与当前的UICC/AJCC rT分期相比,复发性鼻癌 (rNPC) 的新分期系统显示了更好的生存预测. 这种新的RT分期旨在更好地指导rNPC患者的治疗决策.